Submitted By: Charles Mayo / University of Michigan | |
---|---|
Data Element Information | |
Use Case Description(s) | |
Use Case Description | Categorization of disease response to treatment outcome. All instances record the Patient Age and/or the Date at the time of assigning the Patient Treatment Outcome. This information is vital to understanding effectiveness of treatment approaches and for public heath policy guidance |
Estimate the breadth of applicability of the use case(s) for this data element | All cancer care providers |
Healthcare Aims |
|
Maturity of Use and Technical Specifications for Data Element | |
Applicable Standard(s) | N/A |
Additional Specifications | N/A |
Current Use | In limited use in production environments |
Supporting Artifacts |
Snomed CT SCTID- 716618008; NCI Thesarus NCITC- C18919 ; NCIMT- C1518681} |
Extent of exchange | N/A |
Potential Challenges | |
Restrictions on Standardization (e.g. proprietary code) | No restrictions |
Restrictions on Use (e.g. licensing, user fees) | None |
Privacy and Security Concerns | None |
Estimate of Overall Burden | Minor effort to implement collection with positive impact for providers, referrals, and institutions |
Data Element |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cancer Treatment Site of Recurrence
Description
If there is a recurrence, then list sites of recurrence . The AAPM Operational Ontology for Radiation Oncology ( https://aapmbdsc.azurewebsites.net) noted a Delphi process to identify standard values recommended for classification. These were Primary- None Primary - Prostate Primary - Seminal Vesicles Nodal-None Nodal-Pelvic Nodal-Aortic Nodal-Distant Distant-None Distant- CHAARTED-Low Volume Distant- CHAARTED-High Volume Metastatic-Bone Metastatic-Viscera In OORO for each instance record of a Cancer Patient Treatment Outcome, multiple values of Evaluation Site of Recurrence can be selected e.g. Primary- None,Nodal-Distant |
||||||||||
|
Comment